Back to article: To promote or inhibit glioma progression, that is the question for IL-33

FIGURE 1: Schematic of the interplay between glioma cells and the host stromal environment. Tables show the presence of a number of cytokines including IL-33 increased in the interstitial fluid (secretome) of an inflammatory patient-derived glioblastoma xenograft when compared to an immune quiescent tumor. The tumor secretome was assessed using Luminex multiplex assays with human and mouse specific antibodies.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.